Related references
Note: Only part of the references are listed.Resveratrol induces mitochondrial biogenesis in endothelial cells
Anna Csiszar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Flow Activation of AMP-Activated Protein Kinase in Vascular Endothelium Leads to Kruppel-Like Factor 2 Expression
Angela Young et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2
Keisuke Sako et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kruppel-like Factor 2 Inhibits Hypoxia-inducible Factor 1α Expression and Function in the Endothelium
Daiji Kawanami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
Gyeong-Min Do et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
Qing-jun Zhang et al.
CARDIOVASCULAR RESEARCH (2008)
Emerging roles of SIRT1 in vascular endothelial homeostasis
Michael Potente et al.
CELL CYCLE (2008)
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span
Kevin J. Pearson et al.
CELL METABOLISM (2008)
Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis
G. Brandon Atkins et al.
CIRCULATION RESEARCH (2008)
KLF2-dependent, shear stress-induced expression of CD59 - A novel cytoprotective mechanism against complement-mediated injury in the vasculature
Anne R. Kinderlerer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 - Possible role in AMP-activated protein kinase activation
Fan Lan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sirtuins - novel therapeutic targets to treat age-associated diseases
Siva Lavu et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne et al.
NATURE (2007)
SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase
Ilwola Mattagajasingh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol.
Gurjeet Kaur et al.
THROMBOSIS RESEARCH (2007)
Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction
Marcia C. Haigis et al.
GENES & DEVELOPMENT (2006)
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
KM Parmar et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells
S Sen-Banerjee et al.
CIRCULATION (2005)
Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes
RJ Dekker et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor
KM Parmar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a phosphatidylinositol 3-kinase-dependent chromatin-remodeling pathway
JP Huddleson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption - A potential mechanism for resveratrol preconditioning of the heart
S Das et al.
VASCULAR PHARMACOLOGY (2005)
KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation
S SenBanerjee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Share Paper
